Literature DB >> 33834323

Surgical Merits of Open, Laparoscopic, and Robotic Gastrectomy Techniques with D2 Lymphadenectomy in Obese Patients with Gastric Cancer.

Seohee Choi1, Jeong Ho Song2,3, Sejin Lee2,3, Minah Cho2,3,4, Yoo Min Kim2,3,4, Woo Jin Hyung2,3,4, Hyoung-Il Kim5,6,7.   

Abstract

BACKGROUND: Robotic surgery has been widely adopted for complex procedures to overcome technical limitations of open or laparoscopic methods. However, evidence of any subsequent benefit is lacking. This study was undertaken to compare open, laparoscopic, and robotic gastrectomy in technically demanding procedure-D2 dissection in obese patients with gastric cancer.
METHODS: Data collected between 2010 and 2018 on D2 gastrectomy in obese patients with gastric cancer were used to conduct retrospective analysis, comparing short- and long-term outcomes of open, laparoscopic, and robotic techniques.
RESULTS: In a total of 185 patients, there were 69 open, 62 laparoscopic, and 54 robotic gastrectomy procedures. Median ages for respective surgical groups were 66 (interquartile range [IQR]: 61-64 years), 63 (IQR: 59-63), and 59 years (IQR: 56-60 years) (p = 0.009). Early-stage gastric cancer ranked proportionately higher in the laparoscopic group (p = 0.005), but operative times were similar among groups. Estimated blood loss (p < 0.001) and drainage volumes (p = 0.001) were higher in the open group, relative to others. Although a robotic approach performed best in overall compliance and in mean number of retrieved lymph node, observed rates of early or late complications did not differ by technique. The open group experienced significantly poorer overall (p = 0.039) and relapse-free (p < 0.001) survival compared with the laparoscopic or robotic group. Robotic surgery emerged from multivariable Cox regression as a protective factor for relapse-free survival (HR = 0.314, 95% CI 0.116-0.851).
CONCLUSIONS: In obese patients with gastric cancer, robotic gastrectomy with D2 lymphadenectomy proved comparable to open or laparoscopic technique short-term, yielding better long-term outcomes.

Entities:  

Year:  2021        PMID: 33834323     DOI: 10.1245/s10434-021-09952-6

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  3 in total

1.  ASO Author Reflections: Which Subgroups of Patients Could Benefit from Robotic Surgery?

Authors:  Seohee Choi; Hyoung-Il Kim
Journal:  Ann Surg Oncol       Date:  2021-04-19       Impact factor: 5.344

2.  Effects of Remimazolam vs. Sevoflurane Anesthesia on Intraoperative Hemodynamics in Patients with Gastric Cancer Undergoing Robotic Gastrectomy: A Propensity Score-Matched Analysis.

Authors:  Bahn Lee; Myoung Hwa Kim; Hee Jung Kong; Hye Jung Shin; Sunmo Yang; Na Young Kim; Dongwoo Chae
Journal:  J Clin Med       Date:  2022-05-08       Impact factor: 4.964

3.  Effect of Combining Early Chemotherapy with Zhipu Liujunzi Decoction under the Concept of Strengthening and Consolidating Body Resistance for Gastric Cancer Patients and Nursing Strategy.

Authors:  Min Wang; Shujuan Wang; Qiang Su; Tian Ma
Journal:  Contrast Media Mol Imaging       Date:  2021-11-30       Impact factor: 3.161

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.